Not a healthcare professional? Go to the patient or caregiver website.

Search Medical Information

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

Quick Finder

Convenient links to frequently asked questions.
  • Stability Calculator
  • Pfizer Clinical Trials
  • Pfizer samples (for eligible HCPs)
  • Assistance programs (for eligible patients)
  • Report an adverse event or concern about the quality of a Pfizer product
 
Didn’t find what you were looking for? Contact us.
Call 800-438-1985*

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

Chat*

*9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event
Pfizer Safety

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch

News and Announcements

Molecules
COVID-19 MRNA VACCINE DEVELOPMENT PROGRAM: FIRST PARTICIPANTS IN THE U.S.
Read more
April 23, 2020
Approval from German authority to start clinical trial of COVID-19 vaccine
April 15, 2020
COVID-19 Information Update for U.S. Health Care Professionals
April 9, 2020
Pfizer Advances Battle Against COVID-19 on Multiple Fronts
April 8, 2020
U.S. FDA Approves BRAFTOVI® (Encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy.

On April 8th, 2020, Pfizer announced that the U.S....